Anti-aging company Juvenescence Ltd. is hoping to bring a total of 10 candidates from its portfolio companies and academic partnerships into the clinic over the next two years with its recent $50 million series A...

Genfit S.A. (Euronext:GNFT), Loos, France Business: Endocrine/Metabolic, Cardiovascular, Diagnostic Date completed: 2016-10-06 Type: Private placement Raised: EUR33.9 million ($38.1 million) Shares: 1.7 million Price: EUR20 Shares after offering: 28 million Investor: Institutional investors Note: The...

BioGeneration Ventures announced a EUR 25 million ($27.8 million) first close for the firm's third life sciences fund. BioGeneration Capital Fund III is targeting a final close of EUR 50 million ($55.6 million). LPs include...

Lauren Martz, Senior Writer Five years after taking the helm as Sanofi 's president of global R&D, Elias Zerhouni is rounding out his strategy to revamp the division and rebuild the pipeline with the appointment...

A wave of initiatives and funds in the U.K. over the last two years has been flooding the gap between the country's prolific scientific achievements and its comparatively low rate of commercialization. The hope is...

Recent high-profile failures in clinical trials for Alzheimer's disease (AD) have underscored the role that imaging agents could play in identifying the right trial populations and tracking their responses. AC Immune S.A. and Biogen Inc....

A poor understanding of disease biology and a challenging development pathway have kept most drug developers away from the serious pregnancy complication preeclampsia, but A1M Pharma AB has a new approach with a first-in-class therapy...

Last month's opening by Johnson & Johnson of the Houston-based JLABS incubator is being seen as a coup by local leaders hoping to make the city the "third coast" of biotech. But stakeholders inside and...

Women's health and hematology play AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) hired Edward Myles as SVP and CFO. Myles was CFO and COO at Ocata Therapeutics Inc. , which Astellas Pharma Inc. (Tokyo:4503) acquired. Metabolic and cardiovascular company...